Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury

Background/Aims: Recent evidence indicates that peroxisome-proliferator activated receptor (PPAR) agonists protect against ischemia/reperfusion (I/R) injury. Here we investigate the effects of the PPAR-gamma agonists, rosiglitazone and ciglitazone, on the renal dysfunction and injury caused by I/R o...

ver descrição completa

Detalhes bibliográficos
Autor principal: Sivarajah, A (author)
Outros Autores: Chatterjee, PK (author), Patel, NSA (author), Todorovic, Z (author), Hattori, Y (author), Brown, PAJ (author), Stewart, KN (author), Mota-Filipe, H (author), Cuzzocrea, S (author), Thiemermann, C (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
Urology & Nephrology
Texto completo:http://hdl.handle.net/10451/21224
País:Portugal
Oai:oai:repositorio.ul.pt:10451/21224

Texto Completo

http://hdl.handle.net/10451/21224

Registos relacionados